Balter Invenomic Valuation
| BIVRX Fund | USD 17.16 0.25 1.48% |
At this time, the entity appears to be fairly valued. Balter Invenomic shows a prevailing Real Value of $17.15 per share. The current price of the fund is $17.16. We determine the value of Balter Invenomic from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Fairly Valued
Today
Please note that Balter Invenomic's price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. Balter Invenomic shows a prevailing Real Value of $17.15 per share. The current price of the fund is $17.16. We determine the value of Balter Invenomic from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Balter Invenomic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Balter Mutual Fund. However, Balter Invenomic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.16 | Real 17.15 | Hype 17.16 | Naive 17.02 |
The intrinsic value of Balter Invenomic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Balter Invenomic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Balter Invenomic Fund helps investors to forecast how Balter mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Balter Invenomic more accurately as focusing exclusively on Balter Invenomic's fundamentals will not take into account other important factors: About Balter Invenomic Valuation
Our relative valuation model uses a comparative analysis of Balter Invenomic. We calculate exposure to Balter Invenomic's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Balter Invenomic's related companies.The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio , while allowing the size of the short portfolio to fluctuate based on the market opportunity. The fund may invest in equity securities of any type and across all market capitalizations. It may invest in securities of companies operating less than three years and in initial public offerings of securities .
Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |